NEW YORK (GenomeWeb News) – Response Genetics today reported a 32 percent drop year over year in its first-quarter revenues.

For the period ended March 31, the Los Angeles-based molecular diagnostics firm recorded $4 million in revenues, down from $5.9 million a year ago. The company attributed the drop to a decrease in its pharmaceutical-related business, while revenues from its Response DX genetic tests dropped to $3 million from $3.1 million.

Its net loss for the period spiked to $3.1 million, or $.14 per share, from $256,891, or $.01 per share, a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.